Published in Hepatology on December 01, 1991
Benzodiazepine receptor ligands and hepatic encephalopathy: further unfolding of the GABA story. Hepatology (1991) 0.76
Prostacyclin inhibition by indomethacin aggravates hepatic damage and encephalopathy in rats with thioacetamide-induced fulminant hepatic failure. World J Gastroenterol (2005) 0.76
Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C. Aliment Pharmacol Ther (2013) 3.59
Wilson's disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology (1997) 3.52
Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut (2006) 2.53
Primary interferon resistance and treatment response in chronic hepatitis C infection: a pilot study. Lancet (2001) 2.40
Twice-weekly administration of peginterferon-alpha-2b improves viral kinetics in patients with chronic hepatitis C genotype 1. J Viral Hepat (2003) 2.33
Von Willebrand Factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C. Aliment Pharmacol Ther (2013) 2.12
Antioxidant status in patients on chronic hemodialysis therapy: impact of parenteral selenium supplementation. Wien Klin Wochenschr (1997) 2.12
ESPEN Guidelines on Enteral Nutrition: Liver disease. Clin Nutr (2006) 2.11
Durability of SVR in chronic hepatitis C patients treated with peginterferon-α2a/ribavirin in combination with a direct-acting anti-viral. Aliment Pharmacol Ther (2013) 2.04
Postcremation diagnosis from an electric shaver. Lancet (2001) 2.02
Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology (2001) 1.92
Antioxidant status in patients with acute respiratory distress syndrome. Intensive Care Med (1999) 1.91
[Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]. Z Gastroenterol (2010) 1.76
Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut (2003) 1.76
Detection of the His1069Gln mutation in Wilson disease by rapid polymerase chain reaction. Ann Intern Med (1997) 1.64
Blunted thrombopoietin response to interferon alfa-induced thrombocytopenia during treatment for hepatitis C. Hepatology (1998) 1.62
Energy metabolism in acute and chronic renal failure. Am J Clin Nutr (1990) 1.60
Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia (2004) 1.59
Percutaneous nonangiographic insertion of Hickman catheters in marrow transplant recipients by anesthesiologists and intensivists. Anesth Analg (1997) 1.58
Extracorporeal lipid elimination for treatment of gestational hyperlipidemic pancreatitis. Gastroenterology (1993) 1.54
Wilson disease in two consecutive generations: an exceptional family. Am J Gastroenterol (2001) 1.50
Hepatocellular carcinoma in Central Europe: prognostic features and survival. Gut (2001) 1.45
Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol (2000) 1.43
[Hepatitis B and C: incidence and regional distribution of hospitalizations in Austria]. Wien Klin Wochenschr (2000) 1.40
The spectrum of acute renal failure in tumour lysis syndrome. Nephrol Dial Transplant (1999) 1.40
ESPEN guidelines for nutrition in liver disease and transplantation. Clin Nutr (1997) 1.40
[How "toxic" is acidosis?]. Wien Klin Wochenschr (1997) 1.39
High prevalence of the H1069Q mutation in East German patients with Wilson disease: rapid detection of mutations by limited sequencing and phenotype-genotype analysis. J Hepatol (2001) 1.33
Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn's disease. Gastroenterology (1997) 1.27
Has total bowel rest a beneficial effect in the treatment of Crohn's disease? Clin Nutr (1983) 1.25
[Expert opinion on boceprevir- and telaprevir-based triple therapies of chronic hepatitis C]. Z Gastroenterol (2012) 1.17
Malposition of central venous catheters. Incidence, management and preventive practices. Wien Klin Wochenschr (1997) 1.12
Bone disease in vitamin D-deficient patients with Crohn's disease. Dig Dis Sci (1989) 1.11
Cyclosporin in Wegener granulomatosis. Ann Intern Med (1988) 1.10
Prevalence and clinical importance of hypertransaminasaemia in coeliac disease. Eur J Gastroenterol Hepatol (1999) 1.10
Long-term follow-up of chronic hepatitis C patients with sustained virological response to various forms of interferon-based anti-viral therapy. Aliment Pharmacol Ther (2006) 1.09
Effect of anticoagulation on blood membrane interactions during hemodialysis. Kidney Int (1999) 1.08
The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C. Gastroenterology (1999) 1.08
Letter: comparing scoring systems and outcome of patients admitted to a liver intensive care unit with severe variceal bleeding. Aliment Pharmacol Ther (2014) 1.07
Global quality assurance in parenteral nutrition. Clin Nutr (1996) 1.07
Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production. Blood (2000) 1.06
Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission. Hepatology (1989) 1.06
ESPEN Guidelines on Enteral Nutrition: Adult renal failure. Clin Nutr (2006) 1.04
Safety and efficacy of endoscopic balloon dilation for treatment of Crohn's disease strictures. Endoscopy (2006) 1.04
Malposition of a dialysis catheter in the accessory hemiazygos vein. Anesth Analg (1996) 1.03
Neurological and neuropsychiatric spectrum of Wilson's disease: a prospective study of 45 cases. J Neurol (1991) 1.02
Acute renal failure after successful cardiopulmonary resuscitation. Intensive Care Med (2001) 1.01
Successful HCV eradication and inhibition of HIV replication by intravenous silibinin in an HIV-HCV coinfected patient. J Clin Virol (2010) 1.01
Liver biopsy is a useful predictor of response to interferon therapy in chronic hepatitis C. Histopathology (1998) 1.00
Impact of different therapeutic regimens on the outcome of patients with Crohn's disease of the upper gastrointestinal tract. Inflamm Bowel Dis (2001) 1.00
Acidic colonic microclimate--possible reason for false negative hydrogen breath tests. Gut (1988) 1.00
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) for treatment of early-stage gastric diffuse large B-cell lymphoma. Ann Oncol (2004) 1.00
Dental and periodontal disease in patients with cirrhosis--role of etiology of liver disease. J Hepatol (1995) 0.99
Improvement of hepatic encephalopathy treated with flumazenil. Lancet (1988) 0.98
Suppression of haematopoiesis during therapy of chronic hepatitis C with different interferon alpha mono and combination therapy regimens. Gut (2005) 0.98
Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Effects on renal hemodynamics and atrial natriuretic factor. Gastroenterology (1991) 0.98
The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson's disease. Brain (2000) 0.98
Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin. Aliment Pharmacol Ther (2012) 0.97
Screening for celiac disease: a prospective study on the value of noninvasive tests. Am J Gastroenterol (1995) 0.97
Predominance of the HLA-H Cys282Tyr mutation in Austrian patients with genetic haemochromatosis. J Hepatol (1997) 0.96
Plasma immunadsorption treatment in patients with primary focal and segmental glomerulosclerosis. Nephrol Dial Transplant (1998) 0.95
Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation. Eur J Gastroenterol Hepatol (1995) 0.95
Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation. J Clin Pathol (2006) 0.95
Increased gastric and intestinal permeability in patients with Crohn's disease. Am J Gastroenterol (1997) 0.95
Partial pressure of ammonia versus ammonia in hepatic encephalopathy. Hepatology (2000) 0.95
Prevention of upper gastrointestinal bleeding in long-term ventilated patients. Sucralfate versus ranitidine. Am J Med (1989) 0.95
A novel variant of lysosomal acid lipase in cholesteryl ester storage disease associated with mild phenotype and improvement on lovastatin. J Hepatol (1997) 0.94
Beneficial effect of 8-ornithin vasopressin on renal dysfunction in decompensated cirrhosis. Gut (1989) 0.94
Wilson's disease presenting in a family with an apparent dominant history of tremor. J Neurol Neurosurg Psychiatry (2001) 0.93
Influence of hypernatremic-hyperosmolar state on hemodynamics of patients with normal and depressed myocardial function. Crit Care Med (1986) 0.92
Long-term follow-up study of asymptomatic HBsAg-positive voluntary blood donors in Austria: a clinical and histologic evaluation of 242 cases. Hepatology (1987) 0.92
Energy metabolism in patients with acute and chronic liver disease. Hepatology (1990) 0.91
Supraclavicular approach to the subclavian/innominate vein for large-bore central venous catheters. Am J Kidney Dis (1997) 0.91
Chemotherapy for management of localised high-grade gastric B-cell lymphoma: how much is necessary? Ann Oncol (2002) 0.91
Importance of liver and kidney for the utilization of glutamine-containing dipeptides in man. Metabolism (1994) 0.91
Brain dysfunction in fulminant hepatic failure. J Hepatol (1994) 0.90
Screening for Wilson's disease in patients with liver diseases by serum ceruloplasmin. J Hepatol (1997) 0.90
Wilson's disease: evidence of subgroups derived from clinical findings and brain lesions. Neurology (1993) 0.90
Bi-allelic presence of the interleukin-10 receptor 1 G330R allele is associated with cirrhosis in chronic HCV-1 infection. Genes Immun (2005) 0.90
Treatment of severe poisoning with slow release theophylline. Br Med J (Clin Res Ed) (1984) 0.90
Immunoadsorption in severe C4d-positive acute kidney allograft rejection: a randomized controlled trial. Am J Transplant (2006) 0.89
Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP). Ann Oncol (2003) 0.89
Serum levels of gamma-aminobutyric-acid-like activity in acute and chronic hepatocellular disease. Lancet (1983) 0.89
Diagnosing colitis: a prospective study on essential parameters for reaching a diagnosis. Endoscopy (2003) 0.89
An European survey of structure and organisation of nutrition support teams in Germany, Austria and Switzerland. Clin Nutr (2005) 0.88
Efficacy and safety of antiviral therapy in patients with Crohn's disease and chronic hepatitis C. Aliment Pharmacol Ther (2008) 0.88
Stenosis of the common bile duct due to Ormond's disease: case report and review of the literature. J Hepatol (1999) 0.88
Prevalence and clinical significance of GB virus type C/hepatitis G virus coinfection in patients with chronic hepatitis C undergoing antiviral therapy. J Viral Hepat (2010) 0.87
C4d-positive acute humoral renal allograft rejection: effective treatment by immunoadsorption. J Am Soc Nephrol (2001) 0.87
Review article: genetic factors that modify the outcome of viral hepatitis. Aliment Pharmacol Ther (2014) 0.86
2,3-Dimercaptosuccinic acid in human arsenic poisoning. Arch Toxicol (1981) 0.86
Routine fluoroscopic guidance is not required for placement of Hickman catheters via the supraclavicular route. Bone Marrow Transplant (1998) 0.86
Recurrence of hepatitis B in children with serologic evidence of past hepatitis B virus infection undergoing antileukemic chemotherapy. J Hepatol (1989) 0.86
25-hydroxyvitamin D absorption in patients with Crohn's disease and with pancreatic insufficiency. Wien Klin Wochenschr (1997) 0.86
Plasma amino acids in hepatic encephalopathy. J Neural Transm Suppl (1978) 0.85
Gamma-glutamyltranspeptidase (GGTP): its relationship to other enzymes for diagnosis of liver disease. Prog Liver Dis (1976) 0.85
Hepatocellular carcinoma in long-term sustained virological responders following antiviral combination therapy for chronic hepatitis C. J Viral Hepat (2008) 0.85
Early viral kinetics on treatment with pegylated interferon-alpha-2a in chronic hepatitis C virus genotype 1 infection. J Viral Hepat (2003) 0.85
Duodenal perforation secondary to placement of a biliary endoprosthesis diagnosed by multislice computed tomography. Endoscopy (2002) 0.84